Constructive Bio: Constructive Bio launches with 15M seed investment to re-engineer biology, creating new classes of enzymes, pharmaceuticals and biomaterials

Constructive Bio announces its launch as a new UK-based biotechnology company following the completion of a $15 million seed round and an exclusive license from the Medical Research Council ("MRC") to IP developed by Professor Jason Chin's Laboratory (the "Chin Lab") at the MRC Laboratory of Molecular Biology ("MRC-LMB"). The Chin Lab has pioneered the development and application of methods for reprogramming the genetic code of living organisms...